Jeffrey Adam Novack - Apr 24, 2024 Form 3 Insider Report for CareDx, Inc. (CDNA)

Role: Secretary and General Counsel
Signature: /s/ Jeffrey Adam Novack
Stock symbol: CDNA
Transactions as of: Apr 24, 2024
Transactions value $: $0
Form type: 3
Date filed: 5/3/2024, 04:40 PM
Next filing: May 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CDNA	Common Stock						127K	Apr 24, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CDNA	Employee Stock Option (right to buy)							Apr 24, 2024	Common Stock	2.39K	$18.24	Direct	F2
holding	CDNA	Employee Stock Option (right to buy)							Apr 24, 2024	Common Stock	2.15K	$37.25	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Comprised of 7,341 shares of common stock and 119,633 shares of common stock represented by restricted stock units ("RSUs"). The RSUs consist of (1) 5,000 shares granted on November 6, 2021; (2) 7,150 shares granted on April 6, 2022; (3) 1,600 shares granted on August 6, 2022; (4) 11,655 shares granted on November 7, 2022; (5) 7,500 shares granted on April 6, 2023; (6) 10,000 shares granted on June 6, 2023; (7) 10,000 shares granted on July 6, 2023; and (8) 66,728 shares granted on February 1, 2024. Each of the foregoing RSU grants is subject to its own vesting schedule.
F2	The option was originally granted on August 6, 2022. 1/4th of the shares subject to the option vested on August 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.
F3	The option was originally granted on April 6, 2022. 1/4th of the shares subject to the option vested on April 6, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter.